James D. McFadyen

ORCID: 0000-0002-9832-6871
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Platelet Disorders and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Blood Coagulation and Thrombosis Mechanisms
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Atrial Fibrillation Management and Outcomes
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Adipokines, Inflammation, and Metabolic Diseases
  • Hemophilia Treatment and Research
  • Blood properties and coagulation
  • Atherosclerosis and Cardiovascular Diseases
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • COVID-19 Clinical Research Studies
  • Cell Adhesion Molecules Research
  • Acute Myocardial Infarction Research
  • Inflammasome and immune disorders
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • Extracellular vesicles in disease
  • Central Venous Catheters and Hemodialysis
  • Acute Ischemic Stroke Management
  • Blood groups and transfusion
  • Complement system in diseases
  • Lipoproteins and Cardiovascular Health
  • Chemokine receptors and signaling
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Baker Heart and Diabetes Institute
2016-2025

Australian Centre for HIV and Hepatitis Virology Research
2013-2025

Monash University
2016-2025

The Alfred Hospital
2016-2025

The University of Melbourne
2020-2025

Alfred Health
2014-2024

Royal Adelaide Hospital
2022

Universitäts-Herzzentrum Freiburg-Bad Krozingen
2021

University of Freiburg
2021

Melbourne Health
2020

Identifying the molecular mechanisms that promote optimal immune responses to coronavirus disease 2019 (COVID-19) vaccination is critical for future rational vaccine design. Here, we longitudinally profile innate and adaptive in 102 adults after first, second, third doses of mRNA or adenovirus-vectored COVID-19 vaccines. Using a multi-omics approach, identify key differences induced by ChAdOx1-S BNT162b2 correlate with antigen-specific antibody T cell reactogenicity. Unexpectedly, observe...

10.1016/j.xcrm.2023.100971 article EN cc-by-nc-nd Cell Reports Medicine 2023-02-17

VITT has emerged as a rare but serious adverse event linked primarily to adenoviral vector COVID-19 vaccinations, such ChAdOx1-S (Oxford/AstraZeneca) vaccination. The syndrome is characterized by thrombosis with thrombocytopenia, elevated D-dimer, and pathologic platelet factor 4 antibodies within 42 days of Despite dysregulated lipid metabolism underpinning many thrombotic conditions, the role alterations in remains unexplored. Here, we examined plasma lipidome patients compared it those...

10.1016/j.rpth.2025.102677 article EN cc-by-nc-nd Research and Practice in Thrombosis and Haemostasis 2025-01-01

Thrombin is a central regulator of leukocyte recruitment and inflammation at sites vascular injury, function thought to involve primarily endothelial PAR cleavage. Here we demonstrate the existence distinct leukocyte-trafficking mechanism regulated by components haemostatic system, including platelet PAR4, GPIbα fibrin. Utilizing mouse injury model show that thrombin cleavage PAR4 promotes injury. This process negatively GPIbα, as seen in mice with abrogated thrombin-platelet binding...

10.1038/ncomms8835 article EN cc-by-nc-nd Nature Communications 2015-07-23

PI3KC2α is a broadly expressed lipid kinase with critical functions during embryonic development but poorly defined roles in adult physiology. Here we utilize multiple mouse genetic models to uncover role for regulating the internal membrane reserve structure of megakaryocytes (demarcation system) and platelets (open canalicular that results dysregulated platelet adhesion under haemodynamic shear stress. Structural alterations lead enhanced tether formation associated accelerated, yet highly...

10.1038/ncomms7535 article EN cc-by Nature Communications 2015-03-17

Certain patients with antibody-mediated autoimmune disease exhibit poor responses to conventional immunosuppression, including B-cell depletion rituximab. Proteasome inhibitors such as bortezomib demonstrate pleiotropic immunomodulatory effects, direct toxicity antibody-producing cells. Here, we report preliminary evidence for the efficacy of salvage therapy refractory hematological disease. Thirteen treatment episodes in 10 phenomena (autoimmune hemolytic anemia [AIHA; n = 8], acquired...

10.1182/bloodadvances.2016001412 article EN cc-by-nc-nd Blood Advances 2016-11-22

Article5 December 2022Open Access Source DataTransparent process A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein Johannes Zeller orcid.org/0000-0002-8122-9063 Department of Plastic and Hand Surgery, University Freiburg Medical Centre, Faculty the Freiburg, Germany Baker Heart Diabetes Institute, Melbourne, Vic., Australia Contribution: Conceptualization, Data curation, Formal analysis, Supervision, Validation, ​Investigation,...

10.15252/emmm.202216236 article EN cc-by EMBO Molecular Medicine 2022-12-05

Gut ischemia is common in critically ill patients, promoting thrombosis and inflammation distant organs. The mechanisms linking hemodynamic changes the gut to remote organ remain ill-defined. We demonstrate that mouse induces a distinct pulmonary thrombotic disorder triggered by neutrophil macroaggregates. These aggregates lead widespread occlusion of arteries, veins, microvasculature. A similar neutrophil-rich response occurred humans with acute respiratory distress syndrome. Intravital...

10.1126/scitranslmed.aam5861 article EN Science Translational Medicine 2017-09-27

Diabetes is associated with an exaggerated platelet thrombotic response at sites of vascular injury. Biomechanical forces regulate activation, although the impact diabetes on this process remains ill-defined. Using a biomembrane force probe (BFP), we demonstrate that compressive activates integrin α

10.1038/s41467-018-03430-6 article EN cc-by Nature Communications 2018-03-08

Microvesicles (MVs) are small cell-derived vesicles, which mainly released by activated cells. They part of a communication network delivering biomolecules, for example, inflammatory molecules, via the blood circulation to remote cells in body. Platelet-derived MVs known induce vascular inflammation. Research on mediators and mechanisms their effects has attracted major interest. We hypothesize that specific lipids inflammation caused platelet-derived MVs. Liquid chromatography electrospray...

10.1055/s-0039-1683409 article EN cc-by-nc-nd Thrombosis and Haemostasis 2019-08-01

RationaleThe early detection of primary tumours and metastatic disease is vital for successful therapy contingent upon highly specific molecular markers sensitive, non-invasive imaging techniques.We hypothesized that the accumulation activated platelets within a general phenomenon thus represents novel means cancer.Here we investigate unique single chain antibody (scFv), which specifically targets platelets, as biotechnological tool cancer.Methods The scFvGPIIb/IIIa, binds to form platelet...

10.7150/thno.19900 article EN cc-by Theranostics 2017-01-01

Abstract Arterial thrombosis manifesting as heart attack and stroke is the leading cause of death worldwide. Platelets are central mediators that can be activated through multiple activation pathways. Platelet‐derived extracellular vesicles (pEVs), also known platelet‐derived microparticles, granular mixtures membrane structures produced by platelets in response to various activating stimuli. Initial studies have attracted interest on how platelet agonists influence composition pEV proteome....

10.1002/pmic.202300391 article EN cc-by PROTEOMICS 2024-03-31

Rationale: Platelets are increasingly recognized as mediators of tumor growth and metastasis.Hypothesizing that activated platelets in the microenvironment provide a targeting epitope for tumor-directed chemotherapy, we developed an antibody-drug conjugate (ADC), comprised single-chain antibody (scFv) against platelet integrin GPIIb/IIIa (scFvGPIIb/IIIa) linked to potent chemotherapeutic microtubule inhibitor, monomethyl auristatin E (MMAE).Methods: We ADC three components: 1) A scFv which...

10.7150/thno.29146 article EN cc-by Theranostics 2019-01-01

Frailty and delirium are prevalent among older adults admitted to the intensive care unit (ICU) associated with adverse outcomes; however, their relationships have not been extensively explored. This study examined association between frailty mortality length of hospital stay (LOS) in ICU patients, whether associations mediated or modified by an episode delirium.Retrospective analysis data from Australian New Zealand Intensive Care Society Adult Patient Database. A total 149,320 patients...

10.1186/s13613-022-01080-y article EN cc-by Annals of Intensive Care 2022-11-17
Coming Soon ...